What is Indiva?
Founded in 1979 and headquartered in Canada, Indiva has established itself as a leader in quality and innovation within the cannabis sector. As a licensed producer, the company specializes in the creation of premium pre-rolls, flower, capsules, and edible products. Indiva also extends its expertise by providing essential production and manufacturing services to other entities within the industry, demonstrating a robust operational capacity and a diversified business model.
How much funding has Indiva raised?
Indiva has raised a total of $7.2M across 2 funding rounds:
Debt
$4M
Debt
$3.2M
Debt (2019): $4M with participation from Dycar Pharmaceuticals Ltd.
Debt (2020): $3.2M, investors not publicly disclosed
Key Investors in Indiva
Dycar Pharmaceuticals Ltd.
Dycar Pharmaceuticals Ltd. is an entity that has provided debt financing to Indiva, indicating a role in supporting the company's operational or expansionary capital needs.
What's next for Indiva?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated growth and potential market expansion for Indiva. This capital infusion is likely to fuel further product development, enhance manufacturing capabilities, and potentially support strategic partnerships or acquisitions. Indiva's focus on premium products and its service offerings position it to capitalize on evolving consumer preferences and regulatory landscapes in the cannabis industry.
See full Indiva company page
